Literature DB >> 11349772

Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation.

W Derks1, J A De Groot, J A Raymakers, J E Veldman.   

Abstract

The progress of sensorineural hearing loss (SNHL) in patients with cochlear otosclerosis was compared for 19 patients treated with fluoride for 1-5 years and 22 untreated controls. CT scans of eight patients before and after fluoride treatment were evaluated visually. Fluoride therapy arrested the progression of SNHL in the low (250, 500 and 1,000 Hz) (p < 0.001) and high (2 and 4 kHz) (p = 0.008) frequencies. It seemed to be more effective for the higher frequencies in cases with an initial SNHL of < 50 dB. Fluoride administration for 4 years did not seem to be superior to a shorter treatment period (1-2 years). For six patients followed up after discontinuing fluoride therapy there was minimal deterioration in SNHL. There was no clear relationship between the size and site of otospongiotic lesions on CT and the severity of SNHL. Follow-up with CT evaluation did not provide reliable information as to the efficacy of fluoride therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349772     DOI: 10.1080/000164801300043361

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  5 in total

1.  Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis.

Authors:  Alicia M Quesnel; Margaret Seton; Saumil N Merchant; Christopher Halpin; Michael J McKenna
Journal:  Otol Neurotol       Date:  2012-10       Impact factor: 2.311

Review 2.  Cochlear otosclerosis.

Authors:  Sebahattin Cureoglu; Muzeyyen Y Baylan; Michael M Paparella
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-10       Impact factor: 2.064

3.  Post-stapedectomy cochlear otosclerosis.

Authors:  Fred Linthicum
Journal:  Ear Nose Throat J       Date:  2009-04       Impact factor: 1.697

4.  Quantitative assessment of vestibular otopathology in otosclerosis: A temporal bone study.

Authors:  Ömer Hızlı; Serdar Kaya; Patricia A Schachern; Geeyoun Kwon; Michael M Paparella; Sebahattin Cureoglu
Journal:  Laryngoscope       Date:  2015-08-26       Impact factor: 3.325

5.  The effectiveness of audiometric evaluation in drug treatment for otospongiosis.

Authors:  Andy de Oliveira Vicente; Hélio K Yamashita; Oswaldo Laércio Mendonça Cruz; Flavia Barros Suzuki; Norma de Oliveira Penido
Journal:  Braz J Otorhinolaryngol       Date:  2012-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.